A researcher based in Aston Institute for Health and Neurodevelopment has been awarded a prestigious Endeavour Project Grant of £174,495 by Epilepsy Research UK. The grant will fund a 36-month study entitled ‘Lysine Metabolism as a therapeutic target
Researchers at Aston University have contributed to the discovery of a previously unknown way in which cannabidiol (CBD), a non-psychoactive component of cannabis, can reduce seizures in many treatment-resistant forms of childhood epilepsy.